CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Valencia, Valenciana, Comunitat, Spain and 223 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Valencia, Spain and 77 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Valencia, Spain and 94 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Valencia, Spain and 168 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Valencia, Spain and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Valencia, Valenciana, Comunitat, Spain and 73 other locations
This interventional study will evaluate the efficacy and safety of ART0380 as monotherapy in patients whose tumors have a biology to predict...
Phase 2
Valencia, Spain and 14 other locations
The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. ...
Phase 1
Valencia, Spain and 19 other locations
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...
Phase 1
Valencia, Spain and 15 other locations
The purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047:* The side effects seen with GEN...
Phase 1, Phase 2
Valencia, Spain and 35 other locations
Clinical trials
Research sites
Resources
Legal